Pierre Fournier

Pierre Fournier

Auto-generated profile, based on publicly available information

Pierre Fournier

Department of Visceral Surgery, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2016 in Surgery for Obesity and Related Diseases
Verified
Journal Article
Closed access
PFPierre Fournier
Pierre Fournier
DGDaniel Gero
Daniel Gero
ADAnna Dayer-Jankechova
Anna Dayer-Jankechova
PAPierre Allemann
Pierre Allemann
NDNicolas Demartines
Nicolas Demartines
MSMichel Suter
Michel Suter

1 February 2015 in Anaesthesia Critical Care & Pain Medicine
Verified
Journal Article
Closed access
PMphilippe montravers
philippe montravers
PAPascal Augustin
Pascal Augustin
NZNathalie Zappella
Nathalie Zappella
GDGuillaume Dufour
Guillaume Dufour
KAKonstantinos Arapis
Konstantinos Arapis
MDMathieu Desmard
Mathieu Desmard

11 June 2015 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
ADAnna Dayer-Jankechova
Anna Dayer-Jankechova
PFPierre Fournier
Pierre Fournier
PAPierre Allemann
Pierre Allemann
MSMichel Suter
Michel Suter

19 April 2013 in Obesity Surgery
Verified
Journal Article
Open access
PDF file
PMphilippe montravers
philippe montravers
JGJean Guglielminotti
Jean Guglielminotti
NZNathalie Zappella
Nathalie Zappella
MDMathieu Desmard
Mathieu Desmard
CMClaudette Muller
Claudette Muller
PAPascal Augustin
Pascal Augustin
Background We assessed the clinical features and outcome of morbidly obese patients admitted to the intensive care unit (ICU) for management of postoperative peritonitis (POP) following bariatric surgery (BS). Methods In a prospective, observational, surgical ICU cohort, we compared the clinical features, empiric antibiotic therapy, and prognosis of BS patients with those developing POP after conventional surgery (cPOP). Results Overall, 49 BS patients were compared to 134 cPOP patients. BS patients were younger (45 ± 10 versus 63 ± 16 years; p < 0.0001), had lower rates of fatal underlying disease (39 vs 64 %; p = 0.002), and the same SOFA score at the time of reoperation (8 ± 4 vs 8 ± 3; p = 0.8) as the cPOP patients. BS patients had higher proportions of Gram-positive cocci (48 vs 35 %; p = 0.007) and lower proportions of Gram-negative bacilli (33 vs 44 %; p = 0.03), anaerobes (4 vs 10 %; p = 0.04), and multidrug-resistant strains (20 vs 40 %; p = 0.01). Despite higher rates of adequate empiric antibiotic therapy (82 vs 64 %; p = 0.024) and high de-escalation rates (67 % in BS cases and 51 % in cPOP cases; p = 0.06), BS patients had similar reoperation rates (53 vs 44 %; p = 0.278) and similar mortality rates (24 vs 32 %; p = 0.32) to cPOP patients. In multivariate analysis, none of the risk factors for death were related to BS. Conclusions The severity of POP in BS patients resulted in high mortality rates, similar to the results observed in cPOP. Usual empiric antibiotic therapy protocols should be applied to target multidrug-resistant microorganisms, but de-escalation can be performed in most cases.

1 August 2020 in Journal of Visceral Surgery
Verified
Journal Article
Closed access
RKR. Kassir
R. Kassir
LRL. Rebibo
L. Rebibo
LGLaurent Genser
Laurent Genser
ASA. Sterkers
A. Sterkers
MBM.-C. Blanchet
M.-C. Blanchet
JZJ.-M. Zimmermann
J.-M. Zimmermann

1 April 2017 in Medicine
Verified
Journal Article
Open access
PDF file
DMDavid Martin
David Martin
Gaëtan-Romain JoliatGaëtan-Romain Joliat
Gaëtan-Romain Joliat
PFPierre Fournier
Pierre Fournier
CBChristophe Brunel
Christophe Brunel
NDNicolas Demartines
Nicolas Demartines
OGOlivier Gié
Olivier Gié
Gouty panniculitis, characterised by the deposition of monosodium urate crystals in subcutaneous tissue, is a rare clinical manifestation of gout. The case of a 67-year-old man is reported, who presented an erythematous nodule on the upper part of the right buttock suspicious for an abscess. This was in the context of chemotherapy for non-Hodgkin's lymphoma. Histopathologic examination demonstrated gouty panniculitis. Because infection was suspected, an incision was performed. The lesion was found to be densely calcified and friable, without purulent discharge. Therefore, a surgical en-bloc resection was performed. The wound healed slowly initially due to a combination of malnutrition, chemotherapy and infection. A wound infection with Enterococcus faecium was treated with antibiotic therapy (carbapenem for seven days) and local therapy. At 6-week follow up the wound showed good granulation tissue and was healing well by secondary intention. The patient was instructed to continue anti-hyperuricaemic treatment. In patients known to have long-standing hyperuricaemia and gout with nonspecific subcutaneous erythematous nodules, gouty panniculitis should be considered.